Agendia: Elizabeth Hanna
Agendia said that it has appointed Elizabeth Hanna as executive vice president and chief commercial officer. Hanna most recently served as president and CEO at Clinical Genomics. Prior to that, she was president and COO at Origin, a clinical-stage biotech company. She has also previously held commercial and managerial roles at Johnson & Johnson Vision Care and Ortho Clinical Diagnostics, and currently serves on the board of directors for Treace Medical Concepts. She holds a B.S. in chemical engineering from the University of Illinois and an MBA from Harvard Business School.
Seegene: Glen Hansen
Seegene has appointed Glen Hansen as head of scientific and medical affairs of Seegene Technologies, the firm's US subsidiary. Hansen will provide clinical input to new product development and provide product and disease knowledge to targeted medical and scientific thought leaders. Hansen previously served as medical director of the microbiology and molecular diagnostics laboratory at Hennepin County Medical Center in Minneapolis and the University of Minnesota School of Medicine.
Illumina: Carissa Rollins
Illumina has appointed Carissa Rollins as chief information officer. She will report to CEO Francis deSouza. Rollins comes to Illumina from UnitedHealthcare, where she was CIO. There, she was responsible for strategy and technology investments. Prior to UnitedHealthcare, she held executive and leadership roles at Gander Mountain, Kohl's, Manpower Global, and Miller-Coors. Rollins holds an MBA from Marquette University. She is board chair of the Minneapolis YWCA and also serves on the Grand Canyon Conservancy board and T-Mobile's advisory board.
For additional recent items on executive appointments and promotions in omics and molecular diagnostics, please see the People in the News page on our website.